Is sofosbuvir/ledipasvir safe for the hearts of children with hepatitis C virus?
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference30 articles.
1. Hepatitis C in a community in Upper Egypt: risk factors for infection;Medhat;Am J Trop Med Hyg,2002
2. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity;Habib;Hepatology,2001
3. Hepatitis C virus genotype 4 therapy: progress and challenges;Kamal;Liver Int,2011
4. Hepatitis C genotype 4: what we know and what we don’t yet know;Kamal;Hepatology,2008
5. Ribavirin: current role in the optimal clinical management of chronic hepatitis C;Reddy;J Hepatol,2009
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of ledipasvir and sofosbuvir pure certified reference materials for improving quality of pharmaceutical analysis;Journal of Chemical Metrology;2022-12-31
2. Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring;The Egyptian Heart Journal;2020-07-01
3. Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years;The Journal of Pediatrics;2020-04
4. Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments;American Journal of Perinatology Reports;2020-01
5. Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents;Hepatology International;2019-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3